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An efficient in vitro amino acid-incorporating system from Mycobacterium
tuberculosis H37Rv was standardized. Ribonucleic acid (RNA) isolated from
phage-infected M. smegmatis cells served as natural messenger RNA and
directed the incorporation of "C-amino acids into protein. The effects of various
antitubercular drugs and "known inhibitors" of protein synthesis on amino acid
incorporation were studied. Antibiotics like chloramphenicol and tetracycline
inhibited mycobacterial protein synthesis, though they failed to prevent the
growth of the organism. This failure was shown to be due to the impermeability of
mycobacteria to these drugs by use of "membrane-active" agents along with the
antibiotics in growth inhibition studies. Several independent streptomycin-
resistant mutants of M. tuberculosis H37Rv were isolated. Streptomycin
inhibited the incorporation of "C-amino acids into proteins by whole cells of a
streptomycin-susceptible strain by more than 90%, whereas very little or no
inhibition was observed in either high-level or low-level streptomycin-resistant
strains.
In vitro, streptomycin was an effective inhibitor of susceptible strains, whereas
in streptomycin-resistant strains the concentration of streptomycin at which
half-maximal inhibition was produced varied according to the resistance of whole
cells, and there was a correlation between the two. In one low-level streptomycin-
resistant mutant, the in vitro amino acid-incorporating system was as sensitive
to various concentrations of streptomycin as the parental type, and a possible
involvement of a membrane site in the development of low-level resistance was
indicated. Streptomycin susceptibility and high-level resistance were shown to
be ribosomal in nature.
Although the mechanism of protein synthesis
and the action of antibiotics such as strep-
tomycin have been worked out in Escherichia
coli and other organisms in great detail (10, 12),
very little is known about in vitro protein
synthesis and the mode of action of strep-
tomycin in mycobacteria. This is all the more
surprising since the chemotherapy of tuberculo-
sis is getting more complicated as a result of the
occurrence of bacilli resistant to streptomycin.
The observation of Erdos and Ullmann (4, 5)
about the inhibition of protein synthesis by
streptomycin was made in an undefined system
in which "pH 5 enzyme" source devoid of
ribosomes was used. Efficient in vitro protein-
synthesizing systems have so far been described
only from Mycobacterium smegmatis (14) and
BCG (21). The available information on protein
synthesis in mycobacteria was summarized by
Raimakrishnan et al. in a recent review (13). A
systematic and detailed study of protein syn-
thesis in the virulent strain of M. tuberculosis
and the action of streptomycin was therefore
desirable. In this report, we describe an efficient
cell-free system from M. tuberculosis H37Rv
capable of incorporating amino acids into pro-
tein and the inhibitory effect of streptomycin.
The purpose of the present investigation was to
compare the protein synthesis in susceptible
and resistant strains of M. tuberculosis H37Rv
and to localize the site of susceptibility or
resistance to streptomycin. Some features of the
polyuridylic acid (poly U)-dependent in vitro
incorporating system and the effects of several
antimycobacterial drugs and antibiotic inhibi-
tors of protein synthesis are described.
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MATERIALS AND METHODS
Poly-U (K salt), ,B-mercaptoethanol, phospho-
(enol) pyruvate (K salt), pyruvate kinase, adenosine
triphosphate (ATP, trisodium), guanosine triphos-
phate (GTP, trisodium), alumina type 303, erythro-
mycin, puromycin, and yeast ribonucleic acid (RNA)
were from the Sigma Chemical Co., St. Louis, Mo.; E.
coli transfer RNA (tRNA) and yeast tRNA were from
Schwarz-Mann Research Laboratories; streptomycin
sulfate was from Merck, Sharp, Dohme of India Ltd.;
DL-phenylalanine-1-14C (26.6 mCi/mmol) and 14C-
chlorella protein hydrolysate (13 mCi/m-atom) were
from Bhabha Atomic Research Centre, Bombay, In-
dia; rifampin and kanamycin were from Mann Re-
search Laboratories, New York, N.Y.; neomycin was
from the Unichem Laboratories, Bombay, India; p-
amino salicylic acid (PAS), Na salt, was from Rhodia
Chemicals, Paris, France; isonicotinic hydrazide
(INH) was from Dumex (India) Private Ltd., Bom-
bay, India; N', N"°-formyl tetrahydrofolate, Ca salt,
was from the Lederle Laboratories, London, England;
N-methyl-N-nitro-N-nitrosoguanidinQ (NTG) was
from Aldrich Chemical Co., Inc., Milwaukee, Wis.;
and ethyl methane sulfonate (EMS) was from East-
man Kodak Co., Rochester, N.Y.
Growth of the organism and preparation of
cell-free extract. M. tuberculosis H37Rv strain 7416
NCTC, which is streptomycin-susceptible, and the
various mutants derived from it were grown routinely
on the liquid synthetic medium of Youmans and
Karlson (23) as surface cultures. When submerged
cultures were desired, 0.02% (vol/vol) Tween 80 was
incorporated into this medium and the cultures were
incubated at 37 C in a rotary shaker (125 rpm, at a
throw of 3.8 cm).
Mycobacterial cells were harvested after 12 days of
growth and ground with an equal weight of alumina or
glass powder in a prechilled mortar for 10 min. The
resulting paste was suspended in cold 0.01 M tris(hy-
droxymethyl)aminomethane (Tris)-hydrochloride
buffer, pH 7.8, containing 0.01 M maghesium acetate,
0.06 M ammonium chloride, and 0.006 M fi-mercapto-
ethanol (2 to 3 ml of buffer/g of wet weight) and
centrifuged for 45 min at 20,000 x g at 4 C; the
supematant fluid constitutes the S-20 extract. A
100,000 x g supernatant fraction (denoted as S-100)
was prepared, when indicated, by centrifuging the
S-20 extract in a Beckman model L2-50 ultracentri-
fuge at 100,000 x g for 90 min. The top two-third
portion constituted S-100. The remaining superna-
tant fluid was discarded, and the ribosomes were
washed with "standard buffer" (0.01 M Tris-hydro-
chloride, pH 7.8; 0.01 M magnesium acetate, 0.06 M
ammonium chloride, and 0.006 M ,-mercaptoetha-
nol) and pelleted again by centrifuging for 90 min at
100,000 x g. The washed ribosomes were suspended in
the same buffer and stored frozen at - 20 C until use.
The RNA content of the ribosomes was determined
by the method of Ceriotti (3) with yeast RNA as the
standard; the number of ribosomes in the assay
mixture was calculated by the method of Van Dijk-
Salkinoja (22) based on the RNA content.
Protein content of the ribosomes and S-100 extract
was determined by the method of Lowry et al. (9).
Isolation of streptomycin-resistant mutants by
chemical mutagenesis. A 12-day-old culture of M.
tuberculosis H37Rv was inoculated into tubes con-
taining 5 ml of medium with 0.02% (vol/vol) Tween
80. NTG (final concentration, 500 pg/ml) was added
to one of the tubes, and EMS (final concentration,
0.2%) was added to the other. The contents of the
tubes were thoroughly mixed and incubated at 37 C
with shaking. After 1 h, 2.0-ml portions from each
tube were removed and centrifuged, and the cells were
suspended in 2.0 ml of fresh medium. Samples of 0.2
ml were added to Petrik's egg medium (8) containing
1, 10, and 100 gg of streptomycin/ml (all in dupli-
cates). The procedure was repeated at the end of 3 h
except that the centrifuged cells were suspended in
1.0 ml of medium (to compensate for the cell death
due to the action of mutagen). All of the tubes were
incubated at 37 C for 3 weeks. Three steps of purifica-
tion of single colonies were carried out to avoid errors
resulting from clumping of mycobacteria. The puri-
fied mutants were maintained by regular subculture
on Petrik medium.
Similarly, several spontaneous streptomycin-resist-
ant mutants were isolated (by exposing the organisms
to 1 and 2 pg of streptomycin/ml) and purified.
Incorporation of 'IC-amino acids into proteins
by whole cells. Eight-day-old M. tuberculosis H37Rv
cells (or a streptomycin-resistant mutant), grown as a
submerged culture in Youman's medium containing
0.02% (vol/vol) Tween 80, were diluted with fresh
medium so as to contain approximately 1 mg (dry
weight) per ml, and 0.25 pCi of "4C-chlorella protein
hydrolysate/ml was added. At various time intervals,
1 ml of culture was removed into 1 ml of 10%
trichloroacetic acid, heated at 90 C for 30 min, cooled,
and filtered through glass-fiber filters (GF/A, 2.4-cm
circles). The filters were washed with 5% trichloroa-
cetic acid several times, then with a mixture of
ethanol-ether (3:1), and finally with ether. They were
dried and the radioactivity was measured in a Beck-
man LS-100 liquid scintillation spectrometer. The
results were expressed as counts per minute per
milligram of dry weight. This procedure was repeated
in the presence of 100 pg of streptomycin/ml.
Preparation of RNA from phage-infected M.
smegmatis cells. M. smegmatis SN, was grown in the
liquid medium of Youmans and Karlson (23), with
vigorous aeration, to a cell density of 10o cells/ml. The
cells were infected with mycobacteriophage I,, a
transducing phage isolated in this laboratory (19, 20),
at a multiplicity of infection of 0.7, and were allowed
to grow until rise period (about 6 h). The culture
(before lysis started) was chilled and centrifuged in a
Sharples superspeed centrifuge. The cells were
washed with 0.01 M Tris, pH 7.2, containing 0.01 M
magnesium acetate, and RNA from these phage-
infected cells was isolated according to Salser et al.
(15).
Poly U-directed incorporation of 14C-phenyl-
alanine. The reaction mixture contained (in a total
volume of 110 uliters) the following: Tris-hydrochlo-
ride buffer, pH 7.8, at 37 C, 50 mM; ammonium chlo-
ride, 3 mM; magnesium acetate, 15 mM; dithiothrei-
tol, 2 mM; phospho (enol) pyruvate, 10 mM; pyru-
ANTIMICROB. AG. CHEMADTHER.
PROTEIN SYNTHESIS IN M. TUBERCULOSIS 207
vate kinase, 5 gg; GTP, 0.2 mM; 19 L-amino acids
(except L-phenylalanine), 0.1 mM; E. coli tRNA, 100
gg; poly U, 100 gig; S-20 protein, 40 to 80 gig; and
DL-phenylalanine-l- 14C, 50,000 counts/min (1,000
counts/min = 21.7 pmol). All of the components
except poly U and "4C-phenylalanie were mixed and
preincubated at 37 C for 10 min. Drugs or antibiotics
were added, wherever indicated, to the reaction mix-
ture before preincubation. The reaction mixtures were
chilled, "4C-phenylalanine and poly U were added,
and incubation was continued for a further 30 min at
37 C. Samples (100 giliters) were layered onto What-
man 3 MM filter disks which had been treated for 5
min with 100 gliters of 1 N NaOH. This treatment was
necessary to destroy the incorporation due to amino
acyl-tRNA (11). The disks were allowed to stand at
room temperature for about 30 min and then were
dropped into 10% trichloroacetic acid. After the disks
had been washed with 5% trichloroacetic acid,
ethanol-ether (3:1) mixture, and ether, they were
air-dried and counted in a Beckman LS-100 liquid
scintillation spectrometer with the use of a toluene-
based scintillation fluid.
I, RNA-directed incorporation. The conditions
used were similar to those described above except that
formyl tetrahydrofolic acid, 0.4 mM, was added to the
reaction mixture and the Mg2+ concentration was
reduced to 10 mM. In place of '4C-phenylalanine,
"4C-chlorella protein hydrolysate or "4C-leucine was
added, and about 700 gig of I, RNA was used.
Charging of tRNA. The system contained (in a
total volume of 125 gliters) the following: cacodylate
buffer, pH 7.0, 100 mM; magnesium acetate, 10 mM;
ATP (pH 7.0), 2 mM; ammonium chloride, 10 mM;
DL-phenylalanine-1-14C, 50,000 counts/min; S-20 pro-
tein, 40 to 80( gg; various amounts of E. coli tRNA (or
tRNA from other sources), and water if necessary to
make 125 gliters. After incubation at 37 C for 30 min,
100-giliter samples were removed and layered onto
Whatman 3 MM filter disks. After 2 min at room
temperature, they were dropped into 10% trichloroa-
cetic acid, processed, and counted as described above.
RESUTLTS
The age of the culture had a marked influence
on the proteosynthetic activity of S-20 extracts;
maximal activity was obtained in extracts de-
rived from 12-day-old cells. The activity was
drastically reduced when S-20 extract from
14-day-old cells was used, and practically no
activity could be detected with 18-day-old cells.
Kinetics of incorporation. "C-phenylala-
nine incorporation was linear up to 30 min (Fig.
1), and 5- to 10-fold stimulation was observed
over the blank.
Concentration of tRNA. The system was
limiting in endogenous tRNA. Since the
amount of tRNA in M. tuberculosis H37Rv is
one-twentieth of that in E. coli, and also the
nuclease activity of the extract is very high
(unpublished data), it was necessary to add
high concentrations of tRNA to the system. A
concentration of 100 gg oftRNA was suitable for
optimal charging. Heterologous tRNA could be
used in the system (Fig. 2), and good charging
was observed with E. coli tRNA. The higher
incorporation rates observed with E. coli tRNA
may be due to the higher purity of this prepara-
tion as compared with the M. smegmatis tRNA
preparation. In subsequent experiments, we
20-
a-
e-s0
TINE IN MINUTES
FIG. 1. Kinetics of incorporation of "4C-phenylala-
nine into protein. Assay conditions as described in
Materials and Methods.
TIME IN MINUTES
FIG. 2. Amino acid activation of (i) E. Coli tRNA,
(ii) M. smegmatis tRNA, and (iii) yeast tRNA by M.
tuberculosis H37Rv aminoacyl tRNA synthetases.
Assay conditions as described in the text. 14C-
chlorella protein hydrolysate was used for charging;
100 gg amounts of different tRNA were used.
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obtained comparable results using partially pu-
rified M. smegmatis tRNA.
A high concentration of poly U (100 gg/100
iliters) was necessary to produce considerable
stimulation of "IC-phenylalanine incorporation,
which is in contrast to the very small amounts
needed for stimulation of incorporation in other
systems; optimal incorporating ability was ob-
served at a Mg2+ concentration of 15 mM.
Incorporation directed by natural mes-
senger RNA. RNA isolated from phage-
infected M. smegmatis cells exhibited very little
ability to stimulate the incorporation of a mix-
ture of amino acids into proteins; the extent of
stimulation, however, was dependent on the
concentration of added RNA. A concentration
of 0.73 mg per assay was found to be satisfac-
tory. When "4C-leucine was used in place of
"4C-algal protein hydrolysate, the system incor-
porated 15.8 pmol of "4C-leucine per ml.
Effect of various antitubercular drugs on
incorporation. The antitubercular drugs exhib-
ited various degrees of inhibition of incorpora-
tion at the concentrations tested (Table 1). At
high concentrations, certain antitubercular
drugs like PAS, cycloserine, thiacetazone, and
thiosemicarbazide inhibited the incorporation
to a small extent, whereas others like INH,
ethionamide, and pyrazinamide did not show
any inhibitory effect. Aminoglycoside antibiot-
ics inhibited the incorporation strongly even at
low concentrations, streptomycin being most
effective. Fusidic acid and capreomycin also
exhibited marked inhibitory action. It is signifi-
cant to observe that rifampin, which is an
inhibitor ofRNA polymerase, inhibited the poly
U-dependent synthesis of polyphenylalanine
even at low concentrations.
Various antibiotic inhibitors known to inhibit
the synthesis of proteins in other systems were
tested (Table 2). Since all of these antibiotics
inhibited poly U-dependent incorporation of
04C-phenylalanine to a certain extent, the effect
of these inhibitors on the growth of the tubercle
bacilli was evaluated. The site of action of most
of these antibiotics has been established to be at
the level of protein synthesis. Nevertheless,
they did not show any bactericidal action on M.
tuberculosis H37Rv even at a concentration of
10 Ag/ml, suggesting that the lack of action of
these antibiotics on whole cells may be due to
their impermeability to these antibiotics.
Hence, the action of these antibiotics in the
presence of sodium dodecyl sulfate (SDS), a
"membrane-active" agent which has been re-
ported to alter the cellular permeability of other
bacteria (1) as well as that of INH-resistant
TABLE 1. Effect of antitubercular drugs on
4C-phenylalanine incorporationa
Percent inhibition
Drug
10-3M 10-4M l0-IIM 10-7M 10-'M
Streptomycin 80.00 80.00 80.00 70.00 55.00
Rifampin ...... -- 63.30 63.50 29.00
Kanamycin - 69.00 50.30 18.30 -
Fusidic acid - 76.30 72.30 62.20 43.70
Thiosemicarba-
zide .......... 22.50 18.60 13.60 - -
Thiacetazone . 32.80 29.90 0.00 - -
Cycloserine .... 17.30 0.00 0.00 - -
Ethambutol 37.10 31.50 29.80 - -
p-Amino
salicylic acid 46.00 33.00 6.70 - -
Isonicotinic acid
hydrazide .... 0.00 0.00 0.00 - -
Ethionamide ... 0.00 0.00 0.00 - -
Pyrazinamide - 20.00 0.00 - -
Capreomycin ..100.00 100.00 66.20 57.20 50.00
aAssay conditions were as described in the text.
The, drugs were added to the reaction mixture before
the addition of poly U and preincubated for 20 min;
poly U was then added and incubation was continued
for a further 30 min.
TABLE 2. Effect of antibiotics which are known to
inhibit protein synthesis on '4C-phenylalanine
incorporationa
Antibiotic' Percentinhibition
Erythromycin ........................... 40.0
Tetracycline ............................ 37.0
Chloramphenicol ........................ 34.0
Lincomycin ............................. 58.4
Amicetin ............................... 67.2
Sparsomycin ............................ 40.0
Spectinomycin .......................... 69.4
Puromycin .............................. 83.1
a Assay conditions were as described in Materials
and Methods.
b Each present at a concentration of 10-i M.
mutants of M. tuberculosis H37Rv (17), was
studied. If the antibiotics enter the cell in the
presence of SDS, they should prove to be
bactericidal to M. tuberculosis also. The results
presented in Table 3 indicate that these antibi-
otics (even at 1 jig/ml) were bactericidal in the
presence of 0.01% SDS. SDS at this concentra-
tion is not inhibitory by itself.
Properties of streptomycin-resistant
mutants. All of the mutants were found to be
genetically stable and did not revert on re-
peated subculture in drug-free medium. The
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growth of certain spontaneous mutants was slow
in the presence of the antibiotic as compared
with growth in streptomycin-free medium. The
maximal levels of streptomycin which the mu-
tants could tolerate were determined (Table 4).
The mutants were classified into two categories
according to the level of resistance of the cells:
low-level resistant mutants were those which
were susceptible to the antibiotic at concentra-
tions above 100lg/ml, and high-level resistant
mutants were those which could tolerate strep-
tomycin at concentrations above 100 Mg/ml.
None of the mutants, however, was dependent
on streptomycin for growth. These mutants are
presumably single-step mutants, as they were
TABLE 3. Action of antibiotics on the growth of M.
tuberculosis H37Rva
Growth (mg of dry wt)
expressed as percentage
Antibiotic of control
No SDS + SDS
Erythromycin .............. 100.0 0.0
Chloramphenicol ........... 100.0 0.0
Tetracycline ................ 69.0 0.0
Amicetin ................... 50.0 0.0
Lincomycin ................ 69.0 0.0
No antibiotic ............... 100.0
a A 12-day-old M. tuberculosis H37Rv culture was
inoculated into 5.0 ml of medium containing 1 usg of
various antibiotics/ml, with or without 0.01% (wt/vol)
SDS, and incubated at 37 C (all in duplicate tubes).
Growth was judged visually every week for 21 days
at the end of which dry weights were determined.
TABLE 4. Tolerance of streptomycin-resistant
mutants to streptomycina
Isolated Maximal
as re- toeac
Strain Mutagen sistant to to strep-strepto-
tomycin
mycin (,g/ml)
Sm" Rv-1 Spontaneous 1 10
SmR Rv-2 Spontaneous 1 10
SmR Rv-5 Spontaneous 2 2,500
SmR Rv-1/1 Spontaneous 100 2,000
(second-step
mutant, derived
from SmR-Rv-1)
Sm1OR (N)-1 NTG 10 10,000
Sm1o0 (N)-3 NTG 10 1,000
a Various concentrations of streptomycin were
added to 5.0 ml of medium in tubes and incubated for
3 weeks. The growth was judged visually as well as by
determining the dry weight after 3 weeks.
not exposed to graded concentrations of the
drug.
Inhibition of protein synthesis in whole
cells by streptomycin. The incorporation of
"4C-amino acids into proteins by whole cells of
streptomycin-susceptible strains was inhibited
almost completely by 100 ,ug of streptomycin/
ml, whereas in a high-level resistant mutant
very little or no change in protein synthesis was
observed (Fig. 3). The effect of streptomycin on
the incorporation of labeled amino acids into
proteins by a low-level mutant was also studied
and very little inhibition was observed even at a
streptomycin concentration of 100 Mg/ml (Fig.
4).
Effect of streptomycin on poly U-dependent
incorporation of 14C-phenylalanine. The in-
corporation of "4C-phenylalanine, directed by
poly U, was drastically inhibited by strep-
tomycin at low concentrations in the strep-
tomycin-susceptible strain. Figure 5 shows the
extent of inhibition of "4C-phenylalanine incor-
poration as a function of streptomycin concen-
tration. Half-maximal inhibition was observed
at 2.5 x 10- M streptomycin. At the 50%
inhibition point, the number of molecules of
streptomycin was 2.71 x 1012, and the number
of ribosomes present in the reaction mixture
(calculated from the ribosomal RNA content)
was 4.8 x 1012. Hence, the number of molecules
of streptomycin per ribosome was 0.56.
In different streptomycin-resistant mutants,
the extent of inhibition of "4C-phenylalanine
incorporation varied according to the resistance
of the whole cells to streptomycin. The incorpo-
ration was not at all inhibited by streptomycin
when Sm1OR (N)-1 was used. With two other
mutants, the concentration of streptomycin
required for half-maximal inhibition was
10,000-fold higher than with the parental type
(Fig. 5). With one low-level mutant (SmR
Rv-1), the amino acid-incorporating system
exhibited sensitivity to various concentrations
of streptomycin equal to that of the suscreptible
parent.
As can be seen from Table 5, there was a good
correlation between the levels of resistance of
the whole cells and in vitro resistance of the
system.
Ribosomal basis of streptomycin suscepti-
bility and high-level resistance. The amino-
acylation of tRNA, with the use of the mycobac-
terial enzyme and labeled amino acid, was
completely insensitive to the action of strep-
tomycin. Therefore, the target of streptomycin
action may presumably be the ribosome, as in
other well-characterized systems. To test this,
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TIME IN HOURS TIME IN HOURS
FIG. 3. Effect of streptomycin on incorporation of "4C-amino acids into proteins by whole cells of M.
tuberculosis H37Rv and SmR-Rv-5 (streptomycin-resistant strain). Assay conditions as described in the text.
Incorporation of "4C-amino acids into proteins in the absence ofstreptomycin (0) and in the presence of 100 ,g
of streptomycin/mI (0).
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FIG. 4. Incorporation of "4C-amino acids into pro-
teins by whole cells of SmR-Rv-1 (low-level strep-
tomycin-resistant mutant) and the effect of strep-
tomycin. (0) Without streptomycin; (0) 100 isg of
streptomycin/ml.
0 245X10'' 2M5AW01v 2.5xlO0 2-5X10W5x10X10"
CONCENTRATION OF STREPTOMYCIN (M)
FIG. 5. Effect of various concentrations of strep-
tomycin on 14C-phenylalanine incorporation in a poly
U-dependent system from streptomycin-susceptible
and streptomycin-resistant strains. Assay conditions
as described in Materials and Methods (0) Strep-
tomycin-susceptible strain; (0) SmR-Rv-5; (A)
SmRio(N).1; (0) Sm5-Rv-1/1; (A) Sm*-Rv-1.
ribosomes from the susceptible and resistant
strains were separated from the S-20 fraction,
and a cross-mixing experiment was done to
demonstrate that the ribosome is the target of
streptomycin action. As can be seen in Table 6,
the inhibition caused by streptomycin was de-
pendent on the source of the ribosome whereas
0
0
I I I ~ ~--
I
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the supernatant fluid had no effect.
Effect of streptomycin on the growth of
low-level and high-level resistant mutants in
the presence of SDS. The effect of strep-
tomycin on the growth of SmnOR (N)-1 and SmR
Rv-1 mutants in the presence of a membrane-
active agent, SDS, which is known to alter the
permeability in other bacteria (1) as well as in
an INH-resistant mutant of M. tuberculosis
H37Rv (17) was tested. Growth was judged
visually for 21 days in the presence of 0.01%
TABLE 5. Resistance of the in vitro amino
acid-incorporating system from various
streptomycin-resistant strains to inhibition by
streptomycin and comparison with their in vivo
resistancea
Resistance (Mg of
Streptomycin streptomycin/ml)
concn for half-
Strain maximal inhi- In vitro
bition amino acid- Whole
(moles/liter) incorporat- cells
ing system
Sm5 2.25 x 10- 0.0013 0
SmR Rv-5 5.00 x 10-' 24.00 2,500
SmIoR (N)-1 No inhibition Highly re- 10,000
sistant
SmR Rv-1 2.25 x 10' 0.0013 10
SmR Rv-1/1 2.50 x 10-' 11.70 2,000
(second step
mutant derived
from Sm"-Rv-1)
a Assay procedure was as described in Materials
and Methods.
SDS, and later the dry weights were deter-
mined. In SmnoR (N)-1 (high-level mutant),
streptomycin did not inhibit the growth of the
cells at concentrations up to 6,000,ug/ml even
after the permeability had been altered with
SDS, whereas in SmR Rv-1 (low-level mutant)
streptomycin completely inhibited the growth
at 1 sg/ml in the presence of SDS.
DISCUSSION
A systematic description of the amino acid-
incorporating system from mycobacteria was
given for the first time by Rieber and Imaeda
(14). Our system shows marked similarities to
Reiber and Imaeda's system from M.
smegmatis ATCC 607 (i) in its requirement for
high Mg2+ for optimal incorporation (15 mM),
(ii) in its requirement for a high poly U concen-
tration (100 ug per assay), and (iii) in that both
possess high nuclease activity.
RNA isolated from phage-infected M.
smegmatis was able to stimulate the incorpora-
tion of '4C-amino acids into protein, though the
capacity to stimulate was low as compared with
T4 RNA in E. coli (15). Hence, RNA from
phage-infected cells can be used to program the
in vitro synthesis of proteins in M. tuberculosis
H37Rv, although the amount of RNA required
is very high. The messenger RNA fraction in
this RNA preparation may be low, and, there-
fore, high concentrations are required to satu-
rate the amino acid-incorporating system.
The poly U-directed system was used to test
the inhibitory activities of several antitubercu-
lar drugs which include mostly first and second
TABLE 6. 14C-phenylalanine incorporation with ribosomes from susceptible and resistant strains of M.
tuberculosisa
Susceptible Resistant Streptomycin 14C-phenylalanine Percent
concn(M) incorporation ihbtoSupernatant Ribosome Supernatant Ribosome oncn (M) (pmol/0p1 ml) int
+ + _ _ 0 16.32 0
+ + _ _ 10-9 7.40 54.78
+ + _ 10-7 3.93 75.93
_ _ + + 0 12.98 0
_ _ + + 10-9 13.82 0
_ + + - 0 15.37 0
_ + + _ 10-9 6.90 57.71
_ + + _ 10-7 5.25 66.82
+ _ _ + 0 13.82 0
+ _ _ + 10-9 14.17 0
+ _ _ + 10-7 14.78 0
aThe incubation system was as described in Materials and Methods, with 50 Ag of S-100 protein and 20 Ag of
ribosomal protein. S-100 and ribosomes were mixed separately and added to the reaction mixture. The resistant
strain used was a high-level resistant mutant, Sm,0R (N)-1.
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line drugs and other inhibitors of protein synthe-
sis. Among the drugs, streptomycin, kanamy-
cin, rifampin, and capreomycin were highly
effective at low concentrations. Maximal inhibi-
tion obtained with streptomycin was 80 to 85%,
which is similar to the inhibition obtained in
the E. coli system when poly U was used as
messenger (6).
The inhibition of amino acid incorporation by
rifampin indicates that in M. tuberculosis
H37Rv the antibiotic may also act on the
ribosome in addition to its action on RNA
polymerase, as suggested for Bacillus subtilis
(2). Similar results were obtained by Trnka and
Smith (21) in a poly U-directed phenylalanine-
incorporating system from mycobacteria. Ex-
periments with rifampin in a poly U-dependent
incorporating assay indicate that the drug may
act on the translation process by interacting
with the ribosomes, since an excess of poly U
(molar concentration of poly U exceeding that
of rifampin) partially reverses the inhibition of
polyphenylalanine synthesis (M. S. Shaila, K.
P. Gopinathan, and T. Ramakrishnan, Sym-
posium on control mechanisms in cellular proc-
esses, Bhabha Atomic Research Centre, Bom-
bay, India, 1-3 February 1973, in press). More
experiments are needed to understand the pri-
mary site of rifampin action in mycobacteria.
Chloramphenicol and tetracycline at 10 ,ug/ml
did not inhibit the growth of M. tuberculosis
H37Rv, but they did inhibit in vitro protein
synthesis, indicating that the cells may be
impermeable to them. Altering the permeabil-
ity barrier by using SDS enabled these antibiot-
ics to enter the cells, leading to bactericidal
action, presumably by blocking protein synthe-
sis.
The incorporation of "C-amino acids into
proteins by whole cells of streptomycin-suscept-
ible M. tuberculosis H37Rv was almost com-
pletely inhibited by streptomycin, whereas in
the resistant strains-both high-level and low-
level-the incorporation was unaffected. This
suggests that the mechanism of action of strep-
tomycin in M. tuberculosis may be the same as
in other systems.
In the susceptible strain, a very low concen-
tration of streptomycin (2.5 x 10-9 M) was
needed for 50% inhibition of in vitro protein
synthesis, which is 200 times less than the
amount required for 50 % inhibition of E. coli in
vitro protein synthesis (6). This suggests that
the number of ribosomes present in the reaction
mixture may be less than those present in E.
coli system. This view is supported by the
observation that the number of ribosomes per
cell is 2,700 (unpublished data) as compared
with the value of 10,000 in E. coli (6). Further,
the number of active ribosomes capable of
participating in protein synthesis may be few,
since this cell-free preparation was less active
than that reported by Speyer et al. (16) when
the polyphenylsynthesizing ability was com-
pared. At 2.5 x 10-i M, the ratio of strep-
tomycin per ribosome is 0.56. Thus, for blocking
the protein synthesis completely, one molecule
of streptomycin per ribosome is needed.
In the high-level resistant strains, 10,000-fold
more streptomycin is needed to cause half-max-
imal inhibition, indicating that these systems
are resistant to the action of the drug. There is a
good correlation between the levels of resistance
of the cells and the in vitro resistance of the
incorporating system. These results are similar
to those obtained in pneumococci (18). Further,
the results in Table 5 show that susceptibility
and high-level resistance reside in the ribosome
and not in the supernatant fluid, thus resem-
bling the E. coli (7) and other systems.
From the results presented in this paper, it is
clear that a low-level mutant shows the same in
vitro susceptibility as the wild type, whereas the
whole cells are not susceptible to the action of
streptomycin. This suggests that, in this mu-
tant, the site may be located elsewhere than on
the ribosome, presumably on the membrane. To
support this hypothesis, growth inhibition stud-
ies in the presence of a membrane-active agent,
SDS, were carried out. Altering the permeabil-
ity allows streptomycin to enter the low-level
resistant cells, and once inside the cell it proves
to be lethal, for the ribosomes are sensitive. In
contrast, in the high-level resistant mutant,
even though more streptomycin enters as a
result of the action of SDS, the protein synthe-
sis and hence the growth of the organism are not
inhibited, since the ribosomes are resistant to
the antibiotic. Thus, we conclude that in low-
level resistant mutants the origin of resistance is
on the membrane, whereas streptomycin sus-
ceptibility and high-level resistance reside on
the ribosome.
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